ATRC AtriCure, Inc.

NASDAQ
$55.31

AtriCure, Inc. (ATRC) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.7% since its last earnings release on November 3, 2026.

AtriCure Beat Consensus Estimates, Raises Guidance
Tuesday, November 3, 2026 · 4:01 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 4:00 PM ET
Earnings Whisper
-
vs $0.08
Rev est $158.79M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $59.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AtriCure, Inc.

AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.